BAMS
BIIB icon

Bellevue Asset Management (Switzerland)’s Biogen BIIB Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$25.7M Buy
84,030
+12,260
+17% +$3.52M 3.92% 2
2015
Q3 		$20.9M Sell
71,770
-990
-1% -$327K 3.42% 3
2015
Q2 		$29.4M Buy
72,760
+2,030
+3% +$815K 4.08% 1
2015
Q1 		$29.9M Buy
+70,730
New +$27.9M 4.17% 1

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s BIIB Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Biogen (BIIB) stake by 17% in Q4 2015, buying an estimated $3.52M and bringing the position to 84,030 shares worth $25.7M. The position accounts for 3.92% of the portfolio, ranked #2.

Bellevue Asset Management (Switzerland) first reported a position in BIIB in Q1 2015 and has held it in 4 quarters since. The position peaked at $29.9M in Q1 2015. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 84,030 shares of Biogen worth $25.7M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) bought 12,260 Biogen shares in Q4 2015, an estimated $3.52M.
  • Biogen made up 3.92% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #2 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Biogen in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Biogen position peaked at $29.9M in Q1 2015.
  • 970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.